Research
Search
Close
FU Dehao
- Chief Physician, Doctoral Supervisor, Professor
- Department: Orthopedics
- Research Area: Surgery (Orthopedics)
- Research Interests: Mechanism of osteoporosis Bone-targeted drug delivery Clinical study on osteoporotic fracture Study on new therapy of Osteomyelitis Study on materials for bone defect repair
- Contact: fudehao@sjtu.edu.cn
- Sept 2000—Jun 2003 Huazhong University of Science and Technology Master
- Sept 2003—Jun 2006 Huazhong University of Science and Technology Doctor
- Sept 2006—Oct 2013 Union Hospital Tongji Medical College Huazhong University of Science and Technology Attending physician
- Nov 2013—Oct 2018 Union Hospital Tongji Medical College Huazhong University of Science and Technology Associate Professor, Deputy Chief Physician
- Nov 2018—Jul 202 Union Hospital Tongji Medical College Huazhong University of Science and Technology Professor, Chief physician
- Aug 2021—Jan 2023 Shanghai General Hospital Chief of traumatic orthopedics
- Feb 2023—present Shanghai Sixth People's Hospital Professor, Chief physician
- International Association for limb lengthening and reconstruction(ILLRS) member of the Chinese ministry
- International Society for the research and application of Ilizarov Technology (Asami) member of the Chinese ministry
- Societe Intemationale de Chirurgie Orthopedique et de Traumatologie（SICOT）Member of the Chinese Society of traumatic orthopedics
- Member of External Fixation and Limb Reconstruction Professional Committee of Orthopedics Branch of Chinese Medical Doctor Association
- Member of the Youth Committee of the Trauma Society of the Chinese Medical Association
- Bone-Targeted Biomimetic Nanogels Re-Establish Osteoblast/Osteoclast Balance to Treat Postmenopausal Osteoporosis. Small. 2023 Oct 4:e2303494. doi: 10.1002/smll.202303494.
- An intelligent phase transformation system based on lyotropic liquid crystals for sequential biomolecule delivery to enhance bone regeneration.J Mater Chem B . 2023 Mar 14. doi: 10.1039/d2tb02725a.
- Bioinspired Nanovesicles Convert the Skeletal Endothelium-Associated Secretory Phenotype to Treat Osteoporosis. ACS Nano. 2022 Jul 26;16(7):11076-11091. doi: 10.1021/acsnano.2c03781.
- A bone-targeted engineered exosome platform delivering siRNA to treat osteoporosis. Bioactive Materials. 2022 (10): 207-221. 2
- 01/01/2024-12/31/2027
National Natural Science Foundation of China, ¥490,000, 82370889
Study on immune modulatory mechanisms and targeted treatment
strategies of chronic inflammatory bone loss
Role: Project leader - 01/01/2021-12/31/2024
National Natural Science Foundation of China, ¥550,000, 82070911
Experimental study on the treatment of osteoporosis by targeted bone
marrow immune microenvironment
Role: Project leader
- 2015 Excellent Worker of Orthopaedic Physicians Branch of Chinese Medical Doctor Association
- First place in the national final of the 2016 Osteoporotic fracture Forum and the 9th Case Speech Contest of Fangyuan Project
- "Webster Jee Travel Awardee of ICOBR2014" (International Conference on Osteoporosis and Bone Research, 2014)
- Third prize of the 2nd Orthopaedic Standardized Surgery Video Competition of Chinese Medical Doctor Association Orthopaedic Doctor Branch (CAOS) in 2017
- Third prize of "the first Orthopaedic Surgery Case Invitational Competition of China Medical Education Association" in 2018
